patrick.net

Spinalcord inflammation from the covid vaccines 新冠疫苗引起的脊髓炎症💉♿️🩼
PATIENTMAKT PATIENTCV
JAN 2

https://open.substack.com/pub/patientmaktpatientcv/p/spinalcord-inflammation-from-the

READ IN APP

mänskliga manliga ryggraden - 3d-illustration - spinal cord bildbanksfoton och bilder
A study from Korea shows people have a heightened risk of spinal cord inflammation (transverse myelitis) 42 days after covid vaccine injection. The study by the Korean COVID-19 Vaccine Safety Research Committee (CoVaSC), The association between acute transverse myelitis and COVID-19 vaccination in Korea: Self-controlled case series study, published in the European Journal of Neurology

Nicolas Hulscher, MPH at the McCullough Foundation explains:“Overall, people who received a COVID-19 vaccine had a 141% higher risk of developing acute transverse myelitis within 42 days of vaccination compared to other times in their lives.

Concerningly, all vaccine platforms were associated with an increased risk:

AstraZeneca (ChAdOx1-S):
231% increased risk of spinal cord inflammation.
Pfizer (BNT162b2):
99% increased risk of spinal cord inflammation.
Moderna (mRNA-1273):
157% increased risk of spinal cord inflammation.
Johnson & Johnson (Ad26.COV2.S):
233% increased risk of spinal cord inflammation.”
Spinal cord inflammation (transverse myelitis) “damages the insulating material covering nerve cell fibers (myelin). Transverse myelitis interrupts the messages that the spinal cord nerves send throughout the body. This can cause pain, muscle weakness, paralysis, sensory problems, or bladder and bowel dysfunction. Treatment for transverse myelitis includes medications and rehabilitative therapy. Most people with transverse myelitis recover at least partially. Those with severe attacks sometimes are left with major disabilities.”

Reference: COVID-19 'Vaccination' Linked to a 141% Increased Risk of Transverse Myelitis Within 42 Days of Injection 新冠疫苗引起的脊髓炎症
患者市场患者CV
1月2日

在应用程序中阅读

mänskliga manliga ryggraden - 3D 插图 - 脊髓 bildbanksfoton och 图片
韩国的一项研究显示，注射新冠疫苗 42 天后，人们患脊髓炎症（横贯性脊髓炎）的风险更高。 韩国 COVID-19 疫苗安全研究委员会 (CoVaSC) 的研究《韩国急性横贯性脊髓炎与 COVID-19 疫苗接种之间的关联：自我对照病例系列研究》发表在《欧洲神经病学杂志》上

麦卡洛基金会公共卫生硕士 Nicolas Hulscher 解释道：“总体而言，接种了 COVID-19 疫苗的人在接种疫苗后 42 天内患急性横贯性脊髓炎的风险比一生中其他时期高出 141%。

令人担忧的是，所有疫苗平台都与风险增加相关：

阿斯利康 (ChAdOx1-S)：
脊髓炎症的风险增加 231%。
辉瑞（BNT162b2）：
脊髓炎症的风险增加 99%。
Moderna (mRNA-1273):
脊髓炎症的风险增加 157%。
强生公司 (Ad26.COV2.S)：
脊髓炎症的风险增加了 233%。”
脊髓炎症（横贯性脊髓炎）“会损害覆盖神经细胞纤维（髓磷脂）的绝缘材料。 横贯性脊髓炎会中断脊髓神经向全身发送的信息。 这可能会导致疼痛、肌肉无力、瘫痪、感觉问题或膀胱和肠道功能障碍。 横贯性脊髓炎的治疗包括药物治疗和康复治疗。 大多数横贯性脊髓炎患者至少部分康复。 那些受到严重攻击的人有时会留下严重的残疾。”

参考：COVID-19“疫苗接种”与注射 42 天内横贯性脊髓炎的风险增加 141% 相关